{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:41:32Z","timestamp":1761824492173},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,1]]},"DOI":"10.7759\/cureus.57391","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T13:42:16Z","timestamp":1711978936000},"source":"Crossref","is-referenced-by-count":1,"title":["Effect of the Task Approach, Airway Clearance, Kinesthetic Exercise (TASKS) Paediatric Rehabilitation Protocol on Miller-Fisher Syndrome Variant of Guillain-Barr\u00e9 Syndrome: A Case Report"],"prefix":"10.7759","author":[{"given":"Pratiksha A","family":"Warghat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H V","family":"Sharath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakshi","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.10.2171","article-title":"Haemophilus influenzae infection and Guillain-Barr\u00e9 syndrome","volume":"123 ( Pt 10)","author":"Mori M","year":"2000","unstructured":"Mori M, Kuwabara S, Miyake M, et al.. Haemophilus influenzae infection and Guillain-Barr\u00e9 syndrome. Brain. 2000, 123 ( Pt 10):2171-8. 10.1093\/brain\/123.10.2171","journal-title":"Brain"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61665-6","article-title":"Guillain-barr\u00e9 syndrome and h1n1 influenza vaccine in UK children","volume":"378","author":"Verity C","year":"201129","unstructured":"Verity C, Stellitano L, Winstone AM, Andrews N, Stowe J, Miller E. Guillain-barr\u00e9 syndrome and h1n1 influenza vaccine in UK children. Lancet. 201129, 378:1545-6. 10.1016\/S0140-6736(11)61665-6","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27 Suppl","author":"Asbury AK","year":"1990","unstructured":"Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome. Ann Neurol. 1990, 27 Suppl:S21-4. 10.1002\/ana.410270707","journal-title":"Ann Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2001.111165","article-title":"Risk of Guillain-Barr\u00e9 syndrome after measles-mumps-rubella vaccination","volume":"138","author":"Patja A","year":"2001","unstructured":"Patja A, Paunio M, Kinnunen E, Junttila O, Hovi T, Peltola H. Risk of Guillain-Barr\u00e9 syndrome after measles-mumps-rubella vaccination. J Pediatr. 2001, 138:250-4. 10.1067\/mpd.2001.111165","journal-title":"J Pediatr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/0303-8467(94)90038-8","article-title":"Miller fisher syndrome associated with mycoplasma pneumoniae infection: report of a case","volume":"96","author":"Merkx H","year":"1994","unstructured":"Merkx H, De Keyser J, Ebinger G. Miller fisher syndrome associated with mycoplasma pneumoniae infection: report of a case. Clin Neurol Neurosurg. 1994, 96:96-9. 10.1016\/0303-8467(94)90038-8","journal-title":"Clin Neurol Neurosurg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.57.4.686","article-title":"Miller Fisher syndrome and Haemophilus influenzae infection","volume":"57","author":"Koga M","year":"2001","unstructured":"Koga M, Yuki N, Tai T, Hirata K. Miller Fisher syndrome and Haemophilus influenzae infection. Neurology. 2001, 57:686-91. 10.1212\/wnl.57.4.686","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.07.014","article-title":"Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5-14 years old children","volume":"26","author":"Esteghamati A","year":"2008","unstructured":"Esteghamati A, Gouya MM, Keshtkar AA, Mahoney F. Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5-14 years old children. Vaccine. 2008, 26:5058-61. 10.1016\/j.vaccine.2008.07.014","journal-title":"Vaccine"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-217085","article-title":"Miller Fisher syndrome","volume":"2016","author":"Gupta SK","year":"2016","unstructured":"Gupta SK, Jha KK, Chalati MD, Alashi LT. Miller Fisher syndrome. BMJ Case Rep. 2016, 2016:10.1136\/bcr-2016-217085","journal-title":"BMJ Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000160399.08456.7C","article-title":"Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry","volume":"64","author":"Koga M","year":"2005","unstructured":"Koga M, Gilbert M, Li J, et al.. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology. 2005, 64:1605-11. 10.1212\/01.WNL.0000160399.08456.7C","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/PL00000714","article-title":"Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barr\u00e9 syndrome","volume":"57","author":"Yuki N","year":"2000","unstructured":"Yuki N. Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barr\u00e9 syndrome. Cell Mol Life Sci. 2000, 57:527-33. 10.1007\/PL00000714","journal-title":"Cell Mol Life Sci"},{"key":"ref11","article-title":"Miller fisher variant of guillain-barr\u00e9 syndrome: a report of case","volume":"108","author":"Kozminski","year":"2008","unstructured":"Kozminski, Matthew P. Miller fisher variant of guillain-barr\u00e9 syndrome: a report of case. J Am Osteopath Assoc. 2008, 108:51-2.","journal-title":"J Am Osteopath Assoc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i9.1050","article-title":"Reaction of antibodies to Campylobacter jejuni and cytolethal distending toxin B with tissues and food antigens","volume":"25","author":"Vojdani A","year":"2019","unstructured":"Vojdani A, Vojdani E. Reaction of antibodies to Campylobacter jejuni and cytolethal distending toxin B with tissues and food antigens. World J Gastroenterol. 2019, 25:1050-66. 10.3748\/wjg.v25.i9.1050","journal-title":"World J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of guillain-barr\u00e9 syndrome","volume":"7","author":"van Doorn PA","year":"2008","unstructured":"van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of guillain-barr\u00e9 syndrome. Lancet Neurol. 2008, 7:939-50. 10.1016\/S1474-4422(08)70215-1","journal-title":"Lancet Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2013.02.328","article-title":"Diagnosis, treatment and prognosis of Guillain-Barr\u00e9 syndrome (GBS)","volume":"42","author":"van Doorn PA","year":"2013","unstructured":"van Doorn PA. Diagnosis, treatment and prognosis of Guillain-Barr\u00e9 syndrome (GBS). Presse Med. 2013, 42:e193-201. 10.1016\/j.lpm.2013.02.328","journal-title":"Presse Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/jns.12594","article-title":"European Academy of Neurology\/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barr\u00e9 syndrome","volume":"28","author":"van Doorn PA","year":"2023","unstructured":"van Doorn PA, Van den Bergh PY, Hadden RD, et al.. European Academy of Neurology\/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barr\u00e9 syndrome. J Peripher Nerv Syst. 2023, 28:535-63. 10.1111\/jns.12594","journal-title":"J Peripher Nerv Syst"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002063.pub6","article-title":"Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome","volume":"2014","author":"Hughes RA","year":"2014","unstructured":"Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev. 2014, 2014:CD002063. 10.1002\/14651858.CD002063.pub6","journal-title":"Cochrane Database Syst Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8027.2012.00433.x","article-title":"Recent developments and future directions in Guillain-Barr\u00e9 syndrome","volume":"17 Suppl 3","author":"Lehmann HC","year":"2012","unstructured":"Lehmann HC, Hughes RA, Kieseier BC, Hartung HP. Recent developments and future directions in Guillain-Barr\u00e9 syndrome. J Peripher Nerv Syst. 2012, 17 Suppl 3:57-70. 10.1111\/j.1529-8027.2012.00433.x","journal-title":"J Peripher Nerv Syst"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-200110000-00009","article-title":"Epidemiology of the Guillain-Barr\u00e9 syndrome","volume":"14","author":"Govoni V","year":"2001","unstructured":"Govoni V, Granieri E. Epidemiology of the Guillain-Barr\u00e9 syndrome. Curr Opin Neurol. 2001, 14:605-13. 10.1097\/00019052-200110000-00009","journal-title":"Curr Opin Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Yuki N","year":"2012","unstructured":"Yuki N, Hartung HP. Guillain-Barr\u00e9 syndrome. N Engl J Med. 2012, 366:2294-304. 10.1056\/NEJMra1114525","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.47863","article-title":"A brief overview of recent pediatric physical therapy practices and their importance","volume":"15","author":"Srushti Sudhir C","year":"2023","unstructured":"Srushti Sudhir C, Sharath HV. A brief overview of recent pediatric physical therapy practices and their importance. Cureus. 2023, 15:e47863. 10.7759\/cureus.47863","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/237615-effect-of-the-task-approach-airway-clearance-kinesthetic-exercise-tasks-paediatric-rehabilitation-protocol-on-miller-fisher-syndrome-variant-of-guillain-barr-syndrome-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T13:42:22Z","timestamp":1711978942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/237615-effect-of-the-task-approach-airway-clearance-kinesthetic-exercise-tasks-paediatric-rehabilitation-protocol-on-miller-fisher-syndrome-variant-of-guillain-barr-syndrome-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.57391","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,1]]}}}